What does a low alkaline phosphatase indicate in Wilson disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Low Alkaline Phosphatase in Wilson Disease: A Critical Diagnostic Marker

Low serum alkaline phosphatase is a highly specific and sensitive diagnostic marker for acute liver failure due to Wilson disease, particularly when combined with an alkaline phosphatase to total bilirubin ratio <4 and an AST:ALT ratio >2.2 1, 2.

Diagnostic Significance in Acute Liver Failure

Low alkaline phosphatase is pathognomonic for Wilson disease presenting as acute liver failure 3. This finding is particularly valuable because:

  • An alkaline phosphatase to total bilirubin ratio <2 is a Class I, Level B recommendation for suspecting Wilson disease in acute hepatic failure 1
  • An AP:TB ratio <4 provides 94% sensitivity, 96% specificity, and a likelihood ratio of 23 for diagnosing fulminant Wilson disease 2
  • When combined with AST:ALT ratio >2.2 (94% sensitivity, 86% specificity), these tests together achieve 100% diagnostic sensitivity and specificity 2

Clinical Context and Mechanism

The low alkaline phosphatase occurs specifically in the acute/fulminant presentation of Wilson disease, which:

  • Accounts for 6-12% of all acute liver failure cases requiring emergency transplantation 3
  • Predominantly affects young females (4:1 female:male ratio) 3
  • Carries nearly 95% mortality without liver transplantation 3
  • Is often accompanied by Coombs-negative hemolytic anemia 1, 3, 4, 5

Critical pitfall: Low alkaline phosphatase is much less common in chronic presentations of Wilson disease 6. This finding is specifically associated with acute/fulminant presentations, particularly when hemolysis is present—11 of 12 patients with hemolytic anemia had low alkaline phosphatase values 6.

Diagnostic Algorithm for Acute Liver Failure

When evaluating a young patient with acute liver failure, immediately suspect Wilson disease if you observe 3:

  1. Deep jaundice with disproportionately low/mildly elevated transaminases
  2. Low alkaline phosphatase (often strikingly low or virtually undetectable 7, 5)
  3. Low hemoglobin (Coombs-negative hemolysis)
  4. Low cholinesterase
  5. Calculate AP:TB ratio - if <4, Wilson disease is highly likely
  6. Calculate AST:ALT ratio - if >2.2, further supports Wilson disease

Why This Matters for Mortality

Conventional Wilson disease testing (ceruloplasmin, serum copper) is unreliable in acute liver failure 2:

  • Ceruloplasmin by oxidase method: only 21% sensitivity, 84% specificity
  • Ceruloplasmin by nephelometry: 56% sensitivity, 63% specificity
  • Serum copper >200 μg/dL occurs in all Wilson disease cases but also in other causes of acute liver failure 1, 2

The alkaline phosphatase-based approach is superior because it provides rapid diagnosis using readily available laboratory tests, allowing immediate listing for emergency liver transplantation—the only life-saving treatment for fulminant Wilson disease 1, 3, 2.

Mechanism

The exact mechanism for low alkaline phosphatase remains uncertain 6. In vitro studies show that high copper concentrations added to serum do not significantly affect alkaline phosphatase activity 6, suggesting the mechanism is more complex than direct copper inhibition. The finding appears related to massive hepatocyte destruction and copper release, which also drives the associated hemolysis 3, 5.

Bottom line: In any young patient with acute liver failure, unexpectedly low alkaline phosphatase should trigger immediate calculation of AP:TB and AST:ALT ratios and urgent hepatology consultation for potential emergency liver transplantation 1, 3, 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.